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Summary. Flaws in the conduct of randomized trials can lead to biased estimation of the in-
tervention effect. Methods for adjustment of within-trial biases in meta-analysis include the use
of empirical evidence from an external collection of meta-analyses, and the use of expert opin-
ion informed by the assessment of detailed trial information. Our aim is to present methods to
combine these two approaches to gain the advantages of both. We make use of the risk of bias
information that is routinely available in Cochrane reviews, by obtaining empirical distributions
for the bias associated with particular bias profiles (combinations of risk of bias judgements).
We propose three methods:a formal combination of empirical evidence and opinion in a Bayesian
analysis; asking experts to give an opinion on bias informed by both summary trial information
and a bias distribution from the empirical evidence, either numerically or by selecting areas of
the empirical distribution. The methods are demonstrated through application to two example
binary outcome meta-analyses. Bias distributions based on opinion informed by trial informa-
tion alone were most dispersed on average, and those based on opinions obtained by selecting
areas of the empirical distribution were narrowest. Although the three methods for combining
empirical evidence with opinion vary in ease and speed of implementation, they yielded similar
results in the two examples.
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1. Introduction
In a meta-analysis, results from a set of similar studies are combined to summarize evidence
for a specific research question. Meta-analyses are widely used in healthcare research, and
policy decisions taken by organizations such as the UK National Institute for Health and Care
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Excellence often rely on results from relevant meta-analyses. It is therefore important that meta-
analyses, and the systematic reviews from which they are derived, use methods that minimize
bias.
Meta-epidemiological studies of large numbers of meta-analyses provide empirical evidence
to suggest that aspects of trial design may lead to biased estimates of intervention effects. The
recent ‘Risk of bias in evidence synthesis’ (ROBES) study examined the association between the
risk of bias judgements from Cochrane reviews with intervention effect estimates in 228 binary
outcome meta-analyses with completed risk-of-bias tables (Savovic et al., 2017). Cochrane risk-
of-bias tables include judgements of whether the risk of bias is low, high or unclear in relation to
specific aspects of the trialmethods.The results suggested that problemswith randomization and
lack of blinding are on average associated with a modest (approximately 10%) exaggeration of
intervention effect estimates.There is also evidence that trial results that are basedon subjectively
assessed outcomes are more susceptible to bias.
Since high or unclear risk-of-bias judgements are associated with an exaggeration of interven-
tion effect estimates, bias assessments should be incorporated in the analysis and interpretation
ofmeta-analyses. Currently it is unclear how to use the information that is provided in Cochrane
risk-of-bias tables to reduce the effect of known biases on the meta-analyses presented. Two
methods have recently been proposed for adjusting the results of trials that are included in a
meta-analysis for expected biases: by reducing theweighting given to trials at high or unclear risk
of bias, and correcting for average expected bias.Welton et al. (2009) used empirical evidence on
bias from meta-epidemiological studies, whereas Turner et al. (2009) used expert opinion based
on assessment of detailed trial information. Adjustment using empirical evidence requires rela-
tively little work to incorporate published empirical evidence and so is less time consuming than
using elicited opinion. However, it relies on the strong assumption that biases in the new meta-
analysis are exchangeable with those in the meta-epidemiological data. Further, we must allow
for variation in bias across a collection of meta-analyses, and this can lead to imprecise predic-
tions of bias in a new trial in a newmeta-analysis, and hence imprecise effect estimates in a bias-
adjusted meta-analysis. Bias adjustment based on opinion is tailored to the particular studies
that are included in the newmeta-analysis and does not require the exchangeability assumption.
However, elicitation of expert opinion on bias based on trial information alone can be difficult.
The objective of this research is to present methods in which the empirical data-based
approach that was proposed by Welton et al. (2009) and the opinion-based approach that
was proposed by Turner et al. (2009) can be combined to gain the advantages of both, while
making use of the risk-of-bias information that is available in Cochrane reviews. The paper is
organized as follows. We first describe two case-study meta-analyses. We then describe a generic
framework for bias adjustment in a meta-analysis, before showing how to inform the unknown
bias parameters. Next, we briefly describe the existing methods to bias adjustment based on
empirical data-based evidence or opinion.We then propose three approaches to bias adjustment
based on a combination of empirical evidence on bias and opinion. Each method is applied to
the case-study examples.
2. Motivating examples
We selected two case-study meta-analyses from the ROBES database (Savovic et al., 2017),
chosen to include a variety of risk-of-bias judgements for sequence generation, allocation con-
cealment and blinding. The first meta-analysis A comprises 10 randomized controlled trials
(RCTs) comparing intravenous immunoglobin with placebo or no treatment for preventing
sepsis (one or more episodes) in preterm and/or low birth weight infants (Ohlsson and Lacy,
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(a)
(b)
Fig. 1. Trial results for case-study meta-analyses, with the risk of bias assessments for sequence genera-
tion, allocation concealment and blinding (H, U and L denote high, unclear and low risk of bias respectively;
pooled intervention effects were estimated by using a random-effects meta-analysis model (DerSimonian
and Laird 1986)): (a) meta-analysis A (intravenous immunoglobin for prevention of sepsis): (b) meta-analysis
B (antidepressants for treatment of depression)
196 K. M. Rhodes et al.
2004). The second meta-analysis B comprises 25 RCTs comparing antidepressants against a
placebo for treatment of depression in physically ill people (Rayner et al., 2010). The outcome
was response to treatment at 6–8 weeks. For both meta-analyses we judged the outcomes to be
subjectively assessed.
Fig. 1 shows forest plots of trial results for the two meta-analyses, including indicators for
whether the trials were judged to be at low, unclear or high risk of bias for sequence generation,
allocation concealment andblinding.Throughout thepaperwegroup the trials at highorunclear
risk of bias because the proportion of trials with high risk of bias judgements is typically small
(Savovic et al., 2012, 2017).
Risk-of-bias assessments for the trials that were included in the case-study meta-analyses
were independently checked by co-authors of this paper (Savovic´ and Elbers), using the trial
publications. Only a minority of trials were assessed to be at low risk of bias for sequence
generation or allocation concealment. The number of trials that were assessed to be at low risk
of bias for blinding was 5 (50%) for meta-analysis A and 13 (52%) for meta-analysis B. For both
meta-analysis A and meta-analysis B, there were seven different bias profiles (combinations of
high–unclear and low risk of bias judgements for sequence generation, allocation concealment
and blinding). For example, the trial Clapp 1989 inmeta-analysisAwas assessed to be at low risk
of bias for allocation concealment and blinding but unclear risk of bias for sequence generation.
3. Bias adjustment model
Each trial in the meta-analysis is assumed to provide an estimate of the underlying true inter-
vention effect (which may include the effect of biases) and an appropriate distribution is chosen
to allow for sampling error. The two case-study meta-analyses provide data in the form of bino-
mial counts and we used a Bayesian hierarchical logistic regression model, assuming binomial
within-trial likelihoods. The trials at low risk of bias are assumed to provide an unbiased esti-
mate δi of the true intervention effect (e.g. a log-odds-ratio for binary outcome data).We assume
that these have a normal random-effects distribution across trials:
δi ∼N.d, τ2/:
The trials at high or unclear risk of bias are assumed to estimate the same intervention effect δi
as the trials at low risk of bias plus a bias term βi in trial i. We represent our knowledge about
the likely amount of bias by a normal prior distribution for βi, with trial-specific mean and
variance:
βi ∼N.μi,σ2i /:
We expect heterogeneity between trials to be partially explained by adjusting for biases
(Rhodes et al., 2018), and we allow for unexplained heterogeneity τ2 by using a random-effects
model for δi.
This model differs from that proposed by Welton et al. (2009), since we do not specify a
hierarchical prior structure for βi and treat μi and σ2i as fixed parameters.
We perform all analyses in a Bayesian framework. A vague N(0,105) prior distribution was
assigned to the average intervention effect d. We used a uniform(0,2) prior for the between-
trial standard deviation τ , which is sensible for analysis on the log-odds-ratio scale. Posterior
estimates were obtained by using Markov chain Monte Carlo simulation implemented in the
WinBUGS software (version 1.4.3) (Lunn et al., 2000). All the results that are presented were
based on 500000 iterations, following a burn-in period of 25000 iterations, which were sufficient
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to achieve convergence. Convergence was assessed according to the Brooks–Gelman–Rubin
diagnostic tool (Brooks and Gelman, 1998), with three chains starting from widely dispersed
initial values. TheWinBUGS code for fitting the above bias adjustment model is given in section
S1 of the on-line supporting information.
4. Methods for quantifying bias
We describe five different approaches to deriving an informative prior distribution for the bias
in each trial.
4.1. Method 1: data-based approach
We constructed prior distributions for total bias βi in each trial i in the new meta-analysis by
using empirical data-based evidence from an external collection ofmeta-analyses. Eligiblemeta-
analyses were those including trials at low risk of bias and trials at high or unclear risk of bias for
each of the three bias components: sequence generation, allocation concealment and blinding,
and reporting subjectively measured outcomes (so that they were as relevant as possible to the
case-study meta-analyses). On the basis of an extension of ‘model 3’ of Welton et al. (2009),
we used Bayesian hierarchical models to reanalyse data from 64 binary outcome meta-analyses
(866 trials) included in the ROBES database. The mathematical form of the model is given in
section S2 of the on-line supporting information. Although data were available on bias that
is associated with incomplete outcome data, we chose not to consider this source of bias in
our analyses, since the ROBES results showed no evidence of a change in intervention effect
associated with risk of bias for incomplete outcome data (Savovic et al., 2017).
For each bias profile, we derived an empirical predictive distribution for total bias βnew
expected in a new trial with that profile. The derived predictive distributions for bias on the
log(ratio of odds ratios) scale are displayed in Fig. 2 and represent the expected bias that is
associated with a new trial having a specific bias profile rather than having low risk of bias
judgements for sequence generation, allocation concealment and blinding. We shall refer to the
predictive distribution for the relevant bias profile as the data-based distribution for total bias
βi in a trial i in a new meta-analysis with the same bias profile. This distribution serves as the
N.μi,σ2i / prior distribution for total bias βi in a bias adjustment meta-analysis, where themodel
was described in the previous section.
4.2. Method 2: opinion-based approach
As an alternative to using data-based evidence, we consider an approach that was proposed
by Turner et al. (2009). This approach constructs distributions for individual biases affecting a
trial in a new meta-analysis by using elicited opinion on the likely extent of bias, informed by a
detailed assessment of the methodological quality of each trial. Experts are asked to summarize
their beliefs about bias by providing a numerical range representing their uncertainty.
A number of bias assessors were given summary risk-of-bias information for trials in the new
meta-analysis and asked to mark an interquartile range IQR for total bias on the ratio of odds
ratios scale (exp(βi)) in the new trial i relative to a trial at low risk of bias on an elicitation
scale (Fig. 3), such that they expect the bias to be equally likely to lie inside or outside this
range. The bias assessors were not provided with the data-based distribution for the relevant
bias profile (Fig. 2). We chose IQR for elicitation because it has been found that people perform
better at assessing intervals corresponding to lower levels of certainty (O’Hagan et al., 2006).
Bias assessors could write down a numerical range if they wished, and we made clear in the
introductory training session that this could lie beyond the elicitation scale that was provided,
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Fig. 2. Data-based distributions for the bias expected in a new trial, plotted on the log(ratio of odds ratios)
scale and according to the trial’s bias profile
Fig. 3. Elicitation scale for quantifying the extent of bias in a new trial, plotted on the log(ratio of odds ratios)
scale
to avoid anchoring effects (Johnson et al., 2010). Details of our elicitation process are provided
in a later section.
Each elicited IQR on the ratio of odds ratios scale was rounded to the nearest 0.02 on the
log(ratio of odds ratios) scale, mapped to a normal distribution for each trial i, and combined
across assessors j as follows. We assumed that each IQR, on the log(ratio of odds ratios) scale,
represented approximately μij ± 0:67σij as it would under normality and calculated values
for μij and σij. The pooled opinion-based N.μi,σ2i / distribution for bias in each new trial
was based on medians of the means μij and medians of the standard deviations σij of the
assessors’ distributions, i.e. the medians of μij and σij across assessors j are the values that were
used for μi and σi in the bias adjustment model that was described previously. Our method of
pooling the opinion-based bias distributions across assessors was chosen such that the pooled
bias distribution would represent the opinion of a ‘typical’ assessor and not be influenced by
extreme opinions (Turner et al., 2009). We chose this method in preference to linear pooling or
logarithmic pooling, where the pooled opinion represents weakened or strengthened knowledge
respectively in comparison with a single assessor (O’Hagan et al., 2006). We also quantify the
consistency between assessor opinions in a later section.
4.3. Method 3: opinion-based distributions combined statistically with data-based
distributions
The pooled opinion-based distributions that were obtained in method 2 were statistically com-
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bined with the data-based distributions in a Bayesian analysis. We treated the pooled opinion-
based distributions as data and the data-based bias distributions as priors:
μoi ∼N.βi,σ2oi/,
βi ∼N.μdi,σ2di/,
where μoi and σoi are the mean and standard deviation of the pooled opinion-based bias distri-
bution for trial i, and μdi and σdi are the mean and standard deviation of the data-based bias
distribution.
Equivalently, we could have treated the pooled opinion-based bias distributions as prior dis-
tributions and formally combined these with the data-based distributions in a Bayesian analysis.
Posterior estimates of total bias βi in each trial i are used to inform the adjustment for bias in
the meta-analysis, which the data in the new meta-analysis can also update.
This approach could be argued to be the fairest way to combine the empirical data-based
evidence and opinion, but assessors have previously indicated that quantifying the extent of bias
that they expect in a trial is difficult (Turner et al., 2009). We therefore investigated alternatives
in which we provided assessors with a data-based evidence on the estimated amount of bias in
trials with a similar risk of bias assessments in addition to summary risk-of-bias information
for the new trial.
4.4. Method 4: numerical opinions informed by data-based distributions
Method 4 is an alternative to the opinion-based approach (method 2), where assessors are now
providedwith the relevant empirically derived bias distribution for each trial as well as summary
trial information. By considering the characteristics of each new trial together with the data-
based bias distribution for a trial with the relevant bias profile, assessors were asked to mark on
the x-axis of the empirical bias distribution an IQR for total bias in each new trial (Fig. 4). Bias
assessors could disagree with the data-based evidence and provide a numerical range for bias
that lies outside the range of the x-axis. In essence, we ask the assessors to state where, among
trials with the same bias profile as the trial at hand, this trial sits in terms of the magnitude of
its bias. The ranges that were specified were used to form distributions for total bias in each
new trial in the same way as in the opinion-based approach, and we take the same approach to
pooling distributions across assessors.
4.5. Method 5: opinions obtained by selecting areas from data-based distributions
Our final method is similar to method 4. On the basis of the characteristics of each new trial,
Fig. 4. Data-based bias distribution for elicitation of opinion in method 4
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Fig. 5. Data-based bias distribution for elicitation of opinion in method 5
assessors were asked to select an area (e.g. A, B, A + B, B +C + D, A+ B+ C +D) of the
empirical data-based bias distribution for the relevant bias profile in which they expect the bias
in the new trial to lie (Fig. 5). Assessors were asked to choose all areas in which they thought
the bias might possibly lie, so that the area chosen represented their probability distribution for
bias.
Each selected area of the empirical bias distribution is a truncated normal distribution. To
map these to normal distributions for the bias in each new trial, we computed the 25% and
75% quartiles (i.e. an IQR) of the truncated distribution. Each IQR was used to form a normal
distribution for total bias β in each new trial as in methods 2 and 4, which was then pooled
across assessors in the same way as before.
5. Application to case-study meta-analyses
5.1. Elicitation process
We obtained opinions on the likely amount of bias in each trial during a 1-day elicitation event
separated into two sessions. It is recommended that opinion-based prior distributions repre-
sent a breadth of opinions (Kadane, 1986). By increasing the number of assessors, it is more
likely that the full range of opinions is covered, but this comes with increased costs. Conducting
elicitations remotely would have been possible and would have avoided travel and subsistence
costs, but face-to-face elicitations were preferred because experts can find the elicitation process
difficult and it is useful to have facilitators on hand to answer questions (Chaloner and Rhame,
2001; Boobis et al., 2013). We recruited 12 review authors or methodologists to take part in
this event to judge the extent of bias in trials included in two case-study meta-analyses. These
assessors were well motivated and had sufficient knowledge to provide valid and reliable de-
scriptions of their beliefs (Johnson et al., 2010). Invitation e-mails were sent to review authors
and methodologists, and to members of Cochrane Review groups. Potential assessors were eli-
gible if they had detailed experience with the Cochrane risk-of-bias tool (Higgins et al., 2011),
basic knowledge of statistics (e.g. understanding of a normal distribution, median, interquartile
range, mean, standard deviation, odds ratios and confidence intervals), and understanding of
and experience in conducting meta-analyses. Assessors also had no conflicts of interest.
Opinions on the extent of total bias in each new trial were elicited by
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(a) assessors marking their opinion on a scale (for methods 2 and 3);
(b) assessors marking their opinion on the data-based bias distribution (for method 4) and
(c) assessors selecting an area of the data-based bias distribution in which they expect the
bias in the new trial to lie (for method 5).
Each elicitation strategy involved independent assessment of summary trial information, in-
cluding our risk of bias judgements (low, high or unclear risk of bias for sequence generation;
allocation concealment; blinding and incomplete outcome data) and supporting quotes from
the original study references. Details on the trial design used, sample size, participants and
outcomes were provided (see section S3 of the on-line supporting information for an example
trial information sheet). Although the ROBES database provided no empirical evidence of bias
associated with incomplete outcome data (Savovic et al., 2017), assessors were provided with
summary risk-of-bias information for this bias domain in each trial, which they could allow to
influence their opinion.We chose not to provide the assessors with the original study references,
to prevent the trial results from influencing assessor opinions.
The first elicitation session focused on strategy (a). At the start we gave an introductory
presentation to the bias assessors, including details of the case-study meta-analyses, a practice
elicitation exercise, discussion of the difference between uncertainty arising from imperfect
knowledge and uncertainty arising from sampling variation, information on how we measure
bias on the ratio of odds ratio scale and instructions on completing the forms for elicitation
strategy (a). We are confident that assessors understood treatment effect sizes, interquartile
ranges and the ratio of odds ratio quantity.We clarified anymisunderstandings before beginning
the elicitations.
The second session focused on strategies (b) and (c) in which we elicited opinion based on
summary trial information in addition to empirical data-based evidence on bias. This session
began with an introduction to metaepidemiology and the ROBES database, summaries of the
trials and meta-analyses on which the empirical evidence on bias is based and instructions on
completing the forms for elicitation strategies (b) and (c).
Each assessor assessed each trial once, using one of the three elicitation strategies. Each
trial had at least one high–unclear risk of bias judgement (nine trials in meta-analysis A and
22 trials in meta-analysis B). The three strategies were assigned such that they were used an
approximately equal number of times by each assessor. For each elicitation strategy, assessors
were given a sample of 10 or 11 trials (three frommeta-analysis A and seven or eight frommeta-
analysis B). Groups of four assessors used the same strategies for each trial. Trials were given
to assessors in a random order by meta-analysis; two assessors in each group assessed trials in
meta-analysis A first; the remaining two assessed trials in meta-analysis B first. In total, each
trial was assessed 12 times, with four independent assessments for each of the three elicitation
strategies. Examples of each elicitation form are available in section S4 of the on-line supporting
information.
5.2. Descriptive analysis of elicitation data
Opinions on the extent of the total bias in each trial in meta-analysis A and meta-analysis B
are displayed graphically in section S5 of the on-line supporting information. We compare the
opinions from the various elicitation strategies with caution, since the set of assessors is not
the same for each trial and assessors may have different backgrounds and expertise. Opinions
based on empirical bias distributions (elicitation strategy (b)) were usually less uncertain than
those for strategy (a) where assessors did not have access to empirical evidence on bias. We note
that no assessors disagreed with the empirical data-based distribution (their opinions did not
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exceed the range of the x-axis for the empirical distribution plotted). When choosing an area
of the relevant empirical distribution (strategy (c)), most assessors chose at most two quartiles
(50% of the distribution); 19/36 areas chosen by assessors represented 50% of the distribution
and 11/36 areas represented 25% of the distribution. The majority of areas that were chosen
were close to the median of the empirical bias distribution.
5.3. Consistency among assessors
We used intraclass correlation coefficients (ICCs) to investigate similarity of trial-specific bias
distributions across assessors for the three elicitation strategies. We fitted a mixed effects model
to the means of the bias distributions, treating the trials as random effects and assessors as fixed
effects (McGraw and Wong, 1996). The ICC was calculated as the proportion of total variation
that is explained by between-trial variation, and approximate 95% confidence intervals CI were
based on a parametric bootstrapped distribution for the ICC derived from the mixed effects
model.
Inmeta-analysisA, the consistencybetween theassessors for total biaswas low (ICC16%;95%
CI 0–67%) for the plain elicitation scale (strategy (a)), meaning that only 16% of total variation
in bias distributions could be explained by between-trial variation rather than variation between
assessors. Consistency between assessors was moderately high (ICC 65%; 95% CI 33–92%) for
bias marked on the empirical bias distribution (strategy (b)), and also moderately high (ICC
53%; 95% CI 14–88%) for bias marked on a selected area of the empirical bias distribution
(strategy (c)). The ICCs for meta-analysis B were 19% (95% CI 0–47%), 79% (95% CI 65–
90%) and 81% (95% CI 68–91%) for strategies (a), (b) and (c) respectively. The consistency
between assessors is higher for meta-analysis B, particularly in strategies (b) and (c) that used
the empirical bias distributions. This is likely to be because 10/25 (40%) of trials inmeta-analysis
B had the same risk of bias judgements (high–unclear risk of bias) for all three characteristics,
and this combination of risk of bias judgements corresponded to a combination of the narrowest
data-based bias distributions.
Overall these results suggest that bias distributions from different assessors were much more
consistent under strategies (b) and (c) than under strategy (a).
5.4. Comparison of trial-specific bias distributions across methods
For each trial in the case-study meta-analyses we derived informative prior distributions using
each of the five methods for quantifying bias. Across trials in meta-analysis A, the median
(interquartile range) for the average bias on the ratio of odds ratios scale was 0.85 (0.81–0.94)
based on empirical evidence (method 1) and 0.90 (0.81–0.95) based on expert opinion (method
2). Summaries of average bias across trials obtained from methods 3, 4 and 5 were similar
at 0.88 (0.84–0.94), 0.86 (0.80–0.94) and 0.87 (0.78–0.97). Trial-specific bias distributions for
meta-analysis A are displayed in Fig. 6.
Across trials inmeta-analysisA, bias distributionsweremore dispersed on average formethod
2 (opinion-based,median standarddeviation sd 0.16), followedbymethod4 (numerical opinions
informed by data-based distributions, median sd 0.10), method 1 (data-based, median sd 0.09)
and method 3 (opinion and data statistically combined, median sd 0.08). Bias distributions
for method 5 (opinion obtained by selecting areas of data-based distribution) were narrower
on average (median sd 0.06). The pooled opinion-based bias distribution was wider than the
data-based distribution in all except two trials (Fanaroff 1994 and Chirico 1987), for which the
two distributions were very similar in width. With the exception of Tanzer 1997, at high risk of
bias for all three characteristics, the trial-specific bias distributions were similar across methods
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Fig. 6. Meta-analysis A: prior interquartile ranges of each bias distribution (H, U and L denote high, unclear
and low risk of bias respectively): , 1, data based; , 2, opinion based; , 3, opinion and data
statistically combined; , 4, data-informed opinion (numerical); , 5, data-informed opinion (areas)
(Fig. 6). Across all methods, biases in all except two trials (Clapp 1989 and Bussel 1990) were
expected to favour the intervention on average. Bias distributions were narrower for the largest
trial, Fanaroff 1994, and wider, on average, for Bussel 1990, with a single high or unclear risk
of bias judgement for allocation concealment.
Across trials in meta-analysis B, the median (interquartile range) for the average bias on the
ratio of odds ratios scale was 0.81 (0.81–0.92) based on empirical evidence (method 1) and
0.85 (0.79–0.90) based on expert opinion (method 2). Summaries of average bias across trials
obtained by using integrated methods 3, 4 and 5 were again similar at 0.82 (0.80–0.89), 0.81
(0.78–0.90) and 0.82 (0.80–0.92).
Trial-specific bias distributions for meta-analysis B are displayed in section S6 of the on-
line supporting information. Bias distributions were more dispersed on average for method 2
(median sd 0.20), followed bymethod 4 (median sd 0.14),method 1 (median sd 0.08) andmethod
3 (median sd 0.08). Bias distributions for method 5 were narrower on average (median sd 0.05).
5.5. Summary of feedback from assessors
Weasked the assessors to provide feedback onour strategies for eliciting opinion onbias in a new
trial. Responses were received from 11 of the 12 assessors. Table 1 summarizes the feedback. Six
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Table 1. Feedback from assessors
Question response Number of assessors (%)
Question 1: what was your preferred elicitation strategy?
Mark opinion on scale based on trial information alone 3 (27%)
Mark opinion on empirically derived distribution 2 (18%)
Choose area of empirically derived distribution 6 (55%)
Question 2: on a scale of 1 to 5, how difficult did you find marking opinion on bias on a scale?
Not at all difficult 1 2 (18%)
2 2 (18%)
Fair 3 2 (18%)
4 5 (45%)
Very difficult 5 0 (0%)
Question 3: on a scale of 1–5, how difficult did you find marking opinion on the empirically derived distribution?
Not at all difficult 1 1 (9%)
2 4 (36%)
Fair 3 4 (36%)
4 1 (9%)
Very difficult 5 1 (9%)
Question 4: on a scale of 1–5, how difficult did you find choosing an area of the empirically derived distribution?
Not at all difficult 1 3 (27%)
2 5 (45%)
Fair 3 2 (18%)
4 1 (9%)
Very difficult 5 0 (0%)
out of 11 assessors preferred to choose an area of the empirically derived distribution (elicitation
strategy (c)) over marking an opinion on a plain scale or on the empirically derived distribution.
Marking an opinion on a plain scale (strategy (a)) was given higher difficulty ratings by the
assessors, whereas difficulty ratings given to strategies (b) and (c) were fairly similar. However,
the number of assessors was very small, so these findings must be treated with caution.
6. Meta-analysis results
We compared results from six Bayesian meta-analyses: ignoring bias (all trials taken at face
value), and using each of the five sets of informative prior distributions from the five methods
that were described above. Table 2 displays the estimated average intervention effect across
trials and the estimated between-trial heterogeneity variance τ2 resulting from each method
for meta-analysis A, comparing intravenous immunoglobin against a placebo or no treatment
for preventing sepsis (one or more episodes) in preterm and/or low birth weight infants, and
meta-analysis B, comparing antidepressants against a placebo for treatment of depression in
physically ill people.
In meta-analysis A, the results of an unadjusted Bayesian meta-analysis show weak evidence
that the intervention is effective; the estimate of the odds ratio OR is 0.58 (95% credible interval
CrI 0.27–1.00). Adjusting for bias in the meta-analysis by using empirical evidence leads to
an estimate of the average odds ratio of 0.78 (95% CrI 0.35–1.22) which is closer to 1 (null
value) compared with the model that ignores bias (OR 0.58; 95% CrI 0.27–1.00) (Table 2).
The estimate of the intervention odds ratio also moves towards the null value 1 after adjusting
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Table 2. Case-study meta-analysis A results, unadjusted for bias and by using five different
approaches to bias adjustment: posterior medians; with 95% credible intervals in parentheses
Method Intervention effect Heterogeneity
(odds ratio) variance τ2
Meta-analysis A: outcome, sepsis, one or more episodes
Unadjusted Bayesian 0.58 (0.27–1.00) 0.48 (0.02–2.46)
Bias adjusted using method 1, data based 0.78 (0.35–1.22) 0.20 (0.001–2.07)
Bias adjusted using method 2, opinion based 0.67 (0.32–1.07) 0.33 (0.002–2.19)
Bias adjusted using method 3, opinions and
data combined statistically
0.67 (0.32–1.07) 0.34 (0.005–2.13)
Bias adjusted using method 4, data-
informed opinions (numerical)
0.69 (0.33–1.09) 0.31 (0.003–2.10)
Bias adjusted using method 5, data- 0.68 (0.33–1.07) 0.32 (0.002–2.14)
informed opinions (selected areas)
Meta-analysis B: outcome, response to treatment (6–8 weeks)
Unadjusted Bayesian 2.56 (1.94–3.54) 0.12 (0.0005–0.73)
Bias adjusted using method 1, data based 2.30 (1.71–2.77) 0.07 (0.0002–0.63)
Bias adjusted using method 2, opinion based 2.24 (1.69–3.08) 0.08 (0.0002–0.67)
Bias adjusted using method 3, opinions and
data combined statistically
2.29 (1.75–3.15) 0.10 (0.0003–0.70)
Bias adjusted using method 4, data-
informed opinions (numerical)
2.26 (1.72–3.10) 0.09 (0.0001–0.68)
Bias adjusted using method 5, data-
informed opinions (selected areas)
2.28 (1.75–3.11) 0.08 (0.0002–0.64)
for bias by using opinion alone (OR 0.67; 95% CrI 0.32–1.07). The three integrated approaches
using combinations of empirical evidence and opinion to adjust for bias gave very similar results
to those of the model using opinion alone. This is not surprising, given that the data-based and
opinion-based distributions are quite similar (Fig. 6). Overall, there is little evidence for the
effectiveness of intravenous immunoglobulin after adjustment for within-study biases. After
adjustment for bias based on empirical evidence, the estimated between-trial heterogeneity
decreases by 58%, compared with a reduction of approximately 33% when adjusting for bias by
using opinion or a combination of empirical evidence and opinion.
In meta-analysis B, the combined odds ratio comparing antidepressants with control is esti-
mated as 2.56 (95% CrI 1.94–3.54) in an unadjusted Bayesian meta-analysis. After adjusting for
bias by using a combination of empirical evidence and opinion, the pooled intervention odds
ratio is estimated as 2.29 (1.75–3.15) in method 3, 2.26 (1.72–3.10) in method 4 and 2.28 (1.75–
3.11) inmethod 5. These estimates are very similar and lie between the pooled intervention effect
estimates from the data-based approach (OR 2.30; 95% CrI 1.71–2.77) and the opinion-based
approach (OR2.24, 95%CrI 1.69–3.08) to bias adjustment inmeta-analysis. Heterogeneity vari-
ance decreases by 17% after adjusting for bias by using method 3. Reductions in between-trial
heterogeneity variance from adjusting for bias are similar irrespectively of the external evidence
on bias that is used in the meta-analysis. The evidence for the effectiveness of antidepressants
remains strong after adjustment for within-study biases.
The effect of bias adjustment on individual trial results in meta-analysis A and meta-analysis
B is shown in section S7 of the on-line supporting information. In meta-analysis A, odds ratios
less than 1 favour the intervention and so shift towards the null after bias adjustment because
the external evidence suggests that bias is likely to favour the intervention. Odds ratios that are
greater than 1 move further away from the null after bias adjustment in meta-analysis A. In
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meta-analysis B, odds ratios less than 1 favour the control and so move further away from the
null after bias adjustment, whereas odds ratios that are greater than 1 shift towards the null.
The widths of the credible intervals for the intervention odds ratios widen after adjusting for
bias in meta-analysis A but are not very much affected in meta-analysis B because the estimates
tend to be fairly imprecise anyway.
7. Discussion
In this paper we have proposed three newmethods for adjusting the results of ameta-analysis for
the risk of bias in the trials included, by deriving informative prior distributions for total bias in
a trial. The methods are based on combining empirical data with independent expert opinion,
or using the empirical data to elicit expert opinions. Expert opinions that were informed by
empirical data were considerably more consistent than those generated independently. In each
of two example applications, our three new approaches to bias adjustment inmeta-analysis gave
similar results, which were also similar to those obtained by using data-based evidence alone or
expert opinion alone.
In method 3, we elicit expert opinions independently from the empirical data and formally
combine the resulting bias distributions by using Bayes’s rule. This could be argued to be the
most rigorous way to combine the two approaches, but it is more time consuming to implement
and does not provide help to assessors by giving them the empirical distribution as a point
of reference. It was therefore unsurprising that expert opinions were less consistent by using
this approach than for methods 4 and 5. We gave equal importance to the data-based and
opinion-based evidence, but others could choose to assign different weights to the two prior
distributions for bias. In method 4, assessors choose numerical ranges for the total bias in the
new trial by considering the specific characteristics of the new trial together with the empirical
bias distribution. This approach is straightforward to implement since the elicited opinions
directly provide distributions for the bias in each new trial. In method 5, assessors are asked to
choose an area of the empirical bias distribution in which they expect the bias in the new trial
to lie. This approach is arguably the simplest for assessors, but it is more time consuming for
the analyst because the areas need to be mapped to distributions for the bias.
The elicitation strategy that was used in method 5 is more restrictive than those used in
methods 3 and 4, since assessors are confined to selecting from a limited number of possible
areas based on quartiles of the data-based bias distribution. An alternative approach would be
to ask the experts to build up a bias distribution by assigning weights or ‘chips’ to each quartile
(or narrower intervals) of the data-based bias distribution, to represent the probability of the
bias lying in that quartile, in a similar way to Parmar et al. (1994).
The empirical data-based approach makes the strong assumption that the trial-specific biases
in the new meta-analysis are exchangeable with those in the meta-epidemiological data that are
used to provide empirical evidence. In our implementation of this approach, we restricted the
meta-epidemiological data used to subjectively measured outcomes (as in the case-study meta-
analyses) and others could also restrict data to similar medical areas. In other settings, such
restrictions may lead to prior information being based on small data sets with corresponding
loss of precision.
In practice, the results of trials at low risk of bias for specific characteristics may be affected
by other factors, for which the risk of bias has not been formally assessed. The advantage of
using expert opinion on total bias, either alone or combinedwith data-based evidence, is that the
experts can allow all trial information that is provided to influence their opinion on total bias in a
trial.We decided not to elicit opinion on trials at low risk of bias for the three characteristics that
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were assessed, to be consistent with adjustment using the data-based approach which cannot
account for biases within these trials. In practice we recommend that meta-analysts consider
using expert opinion to adjust results of trials with low risk of bias judgements for potential
biases in meta-analysis, although there would be no empirical evidence to use as a point of
reference in the expert elicitation.
Ourmethods make use of risk-of-bias tables that are routinely created as part of Cochrane re-
views and are commonly created also in non-Cochrane reviews (Hopewell et al., 2013), meaning
that the additional work of preparing summary trial information for the elicitation is minimal.
However, the process of eliciting expert opinion is still time consuming and must be carried out
for each trial in a meta-analysis. Phillippo et al. (2018) have proposed a newmethod for network
meta-analysis that provides quantitative assessment of the effects of potential bias adjustments
in each trial, by deriving bias adjustment thresholds which describe the smallest changes to the
data that would result in a change to the overall conclusion of the meta-analysis. By considering
methods that were proposed by Phillippo et al. (2018), the elicitation process could potentially
be reduced by focusing attention on the trials for which bias adjustment is likely to impact the
meta-analysis result.
Several othermethods of adjusting for bias inmeta-analysis have been proposed. Eddy (1989),
Wolpert and Mengersen (2004) and Greenland (2005) constructed separate models to represent
the mechanism of each individual bias and made adjustments by incorporating these into the
likelihood, or by using Monte Carlo simulation methods and approximate adjustments. These
methods are difficult for non-statisticians to implement and are therefore unlikely to be used
in meta-analyses in practice. Our methods are similar in intention but assume simpler forms
for the trial-specific biases. Although our implementation of bias-adjusted meta-analysis using
Markov chain Monte Carlo methods within the WinBUGS software (Lunn et al., 2000) would
be inaccessible to some researchers, an alternative two-stage approach to implementation would
enable the use of conventional meta-analysis methods as used in Turner et al. (2009).
In this paper we focused on adjusting for biases within RCTs included in two binary outcome
meta-analyses. Both meta-analyses included at least one trial at low risk of bias and covered
many combinations of risk-of-bias judgements for the reported design characteristics of interest,
but we note that this is not necessary for application of the methods. The results from different
approaches to bias adjustment were similar in the two case-study meta-analyses, but they might
differ in other examples. At present, there is a lack of empirical evidence on bias in meta-
analyses usingother types of outcomedata suchas continuousor time-to-event data.Data-based
evidence on biases affecting non-randomized studies is also sparse.An advantage of the opinion-
based approach is that it can be used to adjust for bias in meta-analyses including both RCTs
and non-randomized studies. Once meta-epidemiological data sets become available for other
settings, our methods will be applicable to different types of outcome data and study designs.
A limitation is theaccuracyof reporteddesign characteristics. It is possible thatwell-conducted
trials could be poorly reported (Huwiler-Muntener et al., 2002). Previous research suggests that
many trials that were judged to be at unclear risk of bias for sequence generation and alloca-
tion concealment could be reclassified as being at low risk of bias if information that was not
included in the trial publications was obtained (Hill et al., 2002; Vale et al., 2013). In this work,
two co-authors independently checked the risk-of-bias assessments for the trials that were in-
cluded in case-study meta-analyses using the trial publications. Other researchers could request
supporting information from the study authors to validate further against the Cochrane risk-
of-bias judgements. Ideally, we would have carried out sensitivity analyses to assess the effect
of changing the risk of bias from ‘unclear’ to ‘low’. However, in our meta-epidemiological data
set, trials at high risk of bias were sparse.
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We cannot make strong recommendations on which method to use on the basis of applica-
tion to example meta-analyses. It is difficult to identify a potential study that could provide
firm recommendations; simulation studies would not be possible with methods that use expert
opinion. We suggest that the choice of combined method is based on the preferences of the
systematic review authors, and that sensitivity analyses are conducted to assess the effect of the
chosen method on the meta-analysis results. When using any combined method (methods 3–5),
we suggest the use of method 1 (the data-based approach) in a sensitivity analysis. If method
3 (data and opinion statistically combined) is used, the results should also be compared with
method 2 (opinion alone).
In summary, we proposed three new methods that allow adjustment for potential within-trial
biases in meta-analysis, based on evidence from a large collection of published meta-analyses
and opinion informed by trial-specific summaries. These methods make use of the risk-of-bias
information that is available in Cochrane reviews. The three methods for combining empirical
evidence with opinion vary in ease and speed of implementation but yielded similar results in
two example applications.
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